<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Left ventricular aneurysm and pseudoaneurysm following acute myocardial infarction</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Left ventricular aneurysm and pseudoaneurysm following acute myocardial infarction</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Left ventricular aneurysm and pseudoaneurysm following acute myocardial infarction</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James C Fang, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Left ventricular (LV) aneurysms and pseudoaneurysms are two complications of myocardial infarction (MI) that can lead to death or significant morbidity. This topic reviews the diagnosis and management of patients with aneurysms or pseudoaneurysms caused by MI.</p><p>Aneurysms are also found in diseases such as hypertrophic cardiomyopathy and Chagas disease. Their diagnosis and management are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4955.html" rel="external">"Chronic Chagas cardiomyopathy: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/4947.html" rel="external">"Hypertrophic cardiomyopathy: Morphologic variants and the pathophysiology of left ventricular outflow tract obstruction", section on 'Midcavity obstructive HCM'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">LEFT VENTRICULAR ANEURYSM</span></p><p class="headingAnchor" id="H2258400337"><span class="h2">Pathophysiology</span><span class="headingEndMark"> — </span>LV aneurysms are caused by severe ischemic injury to the myocardium. In the early phase of LV aneurysm formation, the histologic findings in the ventricular wall include muscle necrosis and an intense inflammatory reaction. The injured myocardium is gradually replaced with scar tissue formation. The "border zone" of the aneurysm (ie, between the aneurysm and the normal myocardium) is characterized by patchy fibrosis and abnormal alignment of the muscle fibers [<a href="#rid1">1-3</a>].</p><p>In more mature aneurysms, the wall of the aneurysm typically consists of a white fibrous scar and is thin. The scar is composed of hyalinized fibrous tissue  (<a class="graphic graphic_diagnosticimage graphicRef93485" href="/z/d/graphic/93485.html" rel="external">image 1</a>) [<a href="#rid1">1-3</a>]. The endocardial surface is smooth and nontrabeculated  (<a class="graphic graphic_diagnosticimage graphicRef93494" href="/z/d/graphic/93494.html" rel="external">image 2</a>) [<a href="#rid1">1</a>]. The aneurysm is filled with organized clot in over 50 percent of cases  (<a class="graphic graphic_diagnosticimage graphicRef93497" href="/z/d/graphic/93497.html" rel="external">image 3</a> and <a class="graphic graphic_diagnosticimage graphicRef93495" href="/z/d/graphic/93495.html" rel="external">image 4</a>). The mural thrombus may calcify over time and the aneurysmal wall may itself become calcified  (<a class="graphic graphic_diagnosticimage graphicRef93499" href="/z/d/graphic/93499.html" rel="external">image 5</a> and <a class="graphic graphic_diagnosticimage graphicRef93501" href="/z/d/graphic/93501.html" rel="external">image 6</a>). Dense adhesions between the aneurysm and the overlying pericardium are common [<a href="#rid1">1,2</a>].</p><p>These structural changes result in abnormal hemodynamics, metabolic stress, and adverse remodeling that causes or exacerbates preexisting myocardial injury [<a href="#rid4">4-6</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic abnormalities </strong>– In patients with an LV aneurysm, the aneurysmal segment of the LV bulges during systole, which effectively results in loss of forward stroke volume.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic stress</strong> – In patients with an LV aneurysm, the enlarged ventricle causes an increase in wall tension via La Place's Law and an increase in oxygen demand [<a href="#rid7">7</a>]. In the presence of obstructive coronary artery disease, increased metabolic stress may exacerbate angina. (See  <a class="medical medical_review" href="/z/d/html/1472.html" rel="external">"Approach to the patient with suspected angina pectoris"</a>.)</p><p></p><p class="bulletIndent1">The end result of metabolic stress and prolonged ischemia is a globally dilated and dysfunctional LV.</p><p></p><p class="headingAnchor" id="H3"><span class="h2">Epidemiology</span><span class="headingEndMark"> — </span>LV aneurysms are rare and typically occur as a complication of acute MI. Other causes of LV aneurysm include prior cardiac surgery, Chagas disease, and hypertrophic cardiomyopathy.</p><p>In patients with MI who are treated with modern reperfusion techniques (eg, percutaneous coronary intervention), the incidence of LV aneurysm has not been well studied. However, its incidence with modern reperfusion therapy is likely lower than its incidence during the era of widespread thrombolytic use, which was 7 to 19 percent of patients with a Q-wave MI [<a href="#rid8">8,9</a>].</p><p>The risk factors for LV aneurysm after MI include anterior wall infarction, delayed or incomplete reperfusion, and the absence of extensive collateralization. Approximately 70 to 85 percent of LV aneurysms are located in the anterior or apical walls and are associated with total occlusion of the left anterior descending (LAD) coronary artery and the absence of collateralization  (<a class="graphic graphic_diagnosticimage graphicRef93505" href="/z/d/graphic/93505.html" rel="external">image 7</a> and <a class="graphic graphic_diagnosticimage graphicRef93489" href="/z/d/graphic/93489.html" rel="external">image 8</a>) [<a href="#rid1">1-3,10</a>]. Only 10 to 15 percent of LV aneurysms involve the inferior-basal walls  (<a class="graphic graphic_diagnosticimage graphicRef93492" href="/z/d/graphic/93492.html" rel="external">image 9</a> and <a class="graphic graphic_diagnosticimage graphicRef93490" href="/z/d/graphic/93490.html" rel="external">image 10</a>). Lateral LV aneurysms are exceedingly rare, in part due to the dual blood supply from either the LAD or the right coronary artery  (<a class="graphic graphic_figure graphicRef94853" href="/z/d/graphic/94853.html" rel="external">figure 1</a>) [<a href="#rid1">1-3,10</a>].</p><p class="headingAnchor" id="H496849170"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>In patients with acute MI, the presence of an LV aneurysm is typically identified with imaging performed for diagnosis and management of acute MI. Among patients who present remotely from the index acute MI, the aneurysm may be detected during the evaluation of worsening signs or symptoms, which include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Angina </strong>– In patients with an LV aneurysm, increased oxygen consumption caused by elevated filling pressure and wall tension may promote angina.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Heart failure</strong> – In patients with an MI significant enough to cause an LV aneurysm, LV systolic dysfunction is typically present. In our experience, most patients with an LV aneurysm have heart failure (HF) symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ventricular arrhythmias </strong>–<strong> </strong>Ventricular arrhythmias are common in patients with an LV aneurysm. In addition to the common mechanisms of ventricular arrhythmias in patients with LV systolic dysfunction, patients with an LV aneurysm are prone to scar-related reentrant arrhythmias, which occur at the border zone between the aneurysmal and normal portions of the LV wall [<a href="#rid11">11-13</a>]. (See  <a class="medical medical_review" href="/z/d/html/952.html" rel="external">"Enhanced cardiac automaticity"</a> and  <a class="medical medical_review" href="/z/d/html/954.html" rel="external">"Reentry and the development of cardiac arrhythmias"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic embolization</strong> – Patients with an LV aneurysm rarely present with stroke or systemic embolization [<a href="#rid14">14,15</a>]. However, a mural thrombus is present at autopsy or during surgery in more than 50 percent of patients with LV aneurysm [<a href="#rid2">2,11,16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sudden death </strong>– Patients with an LV aneurysm may present with sudden death as the result of a ventricular arrhythmia or aneurysm rupture [<a href="#rid17">17</a>]. (See <a class="local">'Prognosis and risk of rupture'</a> below.)</p><p></p><p class="headingAnchor" id="H2786070257"><span class="h2">Evaluation for LV aneurysm</span><span class="headingEndMark"> — </span>The evaluation for LV aneurysm includes the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>History and physical examination</strong> – A history of MI is the most common history among patients with an LV aneurysm. Cardiac surgery, Chagas disease, and hypertrophic cardiomyopathy are less common diseases that cause LV aneurysm.</p><p></p><p class="bulletIndent1">The physical examination may reveal one or more of the following findings:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiac enlargement with a diffuse apical impulse that is displaced to the left of the midclavicular line. (See  <a class="medical medical_review" href="/z/d/html/1081.html" rel="external">"Examination of the precordial pulsation"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An area of dyskinesis can occasionally be appreciated with palpation of the apex or left lateral chest wall, in the area of the anterior wall of the LV.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A third or fourth heart sound is often heard, indicating blood flow into a dilated and stiffened LV chamber. (See  <a class="medical medical_review" href="/z/d/html/1079.html" rel="external">"Auscultation of heart sounds"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A systolic murmur of mitral regurgitation may be appreciated due to the distortion of LV geometry that results in the absence of leaflet apposition, tethering of the chordae, papillary muscle dysfunction, and/or annular dilation. (See  <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG </strong>– The electrocardiogram may record evidence of a large anterior MI or persistent ST-segment elevation, but these findings are not specific for LV aneurysm and could represent a large scar without aneurysm formation  (<a class="graphic graphic_waveform graphicRef74283" href="/z/d/graphic/74283.html" rel="external">waveform 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiograph</strong> – The presence of an LV aneurysm may be identified on chest radiography  (<a class="graphic graphic_diagnosticimage graphicRef93490" href="/z/d/graphic/93490.html" rel="external">image 10</a> and <a class="graphic graphic_diagnosticimage graphicRef93505" href="/z/d/graphic/93505.html" rel="external">image 7</a> and <a class="graphic graphic_diagnosticimage graphicRef93489" href="/z/d/graphic/93489.html" rel="external">image 8</a> and <a class="graphic graphic_diagnosticimage graphicRef93482" href="/z/d/graphic/93482.html" rel="external">image 11</a>), but other imaging techniques are more likely to establish the presence or absence of an LV aneurysm.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial imaging (echocardiography) </strong>– In patients suspected of having an LV aneurysm, echocardiography is typically the first step in evaluation  (<a class="graphic graphic_movie graphicRef62247" href="/z/d/graphic/62247.html" rel="external">movie 1</a> and <a class="graphic graphic_movie graphicRef72045" href="/z/d/graphic/72045.html" rel="external">movie 2</a>) [<a href="#rid18">18,19</a>]. In most patients, echocardiography is sufficient to establish the diagnosis. In patients with nondiagnostic echocardiographic images or who require further characterization of the ventricular wall (eg, to differentiate between aneurysm and pseudoaneurysm), additional imaging may be required.</p><p></p><p class="bulletIndent1">The echocardiographic appearance of an LV aneurysm includes a large area of myocardium that is akinetic or dyskinetic during systole and abnormal ventricular wall deformation during diastole. LV aneurysms arise from a broad base or "neck"  (<a class="graphic graphic_movie graphicRef62247" href="/z/d/graphic/62247.html" rel="external">movie 1</a> and <a class="graphic graphic_movie graphicRef72045" href="/z/d/graphic/72045.html" rel="external">movie 2</a>), which differentiates them from the smaller neck of an LV pseudoaneurysm. (See <a class="local">'Diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional imaging</strong> – In patients in whom echocardiography cannot definitively establish the diagnosis of LV aneurysm, we typically obtain cardiovascular magnetic resonance (CMR) imaging, which is considered the gold standard for diagnosis of LV aneurysm. If CMR imaging cannot be obtained (eg, in the presence of retained or implanted metallic bodies), other options for the diagnosis of LV aneurysm include coronary computed tomographic angiography (CCTA), radionuclide ventriculography, and contrast ventriculography. Examples of LV aneurysm imaging findings include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>CMR  (<a class="graphic graphic_diagnosticimage graphicRef93512" href="/z/d/graphic/93512.html" rel="external">image 12</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>CCTA  (<a class="graphic graphic_figure graphicRef94853" href="/z/d/graphic/94853.html" rel="external">figure 1</a> and <a class="graphic graphic_diagnosticimage graphicRef93494" href="/z/d/graphic/93494.html" rel="external">image 2</a> and <a class="graphic graphic_diagnosticimage graphicRef93497" href="/z/d/graphic/93497.html" rel="external">image 3</a> and <a class="graphic graphic_diagnosticimage graphicRef93495" href="/z/d/graphic/93495.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef93499" href="/z/d/graphic/93499.html" rel="external">image 5</a> and <a class="graphic graphic_diagnosticimage graphicRef93501" href="/z/d/graphic/93501.html" rel="external">image 6</a> and <a class="graphic graphic_diagnosticimage graphicRef93492" href="/z/d/graphic/93492.html" rel="external">image 9</a> and <a class="graphic graphic_diagnosticimage graphicRef93483" href="/z/d/graphic/93483.html" rel="external">image 13</a> and <a class="graphic graphic_diagnosticimage graphicRef93487" href="/z/d/graphic/93487.html" rel="external">image 14</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Radionuclide ventriculography  (<a class="graphic graphic_diagnosticimage graphicRef93508" href="/z/d/graphic/93508.html" rel="external">image 15</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Contrast ventriculography  (<a class="graphic graphic_diagnosticimage graphicRef93487" href="/z/d/graphic/93487.html" rel="external">image 14</a> and <a class="graphic graphic_diagnosticimage graphicRef93509" href="/z/d/graphic/93509.html" rel="external">image 16</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment for LV thrombus</strong> – In patients diagnosed with an LV aneurysm, a dedicated study for assessment of LV thrombus should be performed. The approach to diagnosis of LV thrombus is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/90.html" rel="external">"Left ventricular thrombus after acute myocardial infarction", section on 'Diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H2221167758"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>For the purpose of this topic review, an LV aneurysm is a well-delineated area of myocardium that is thin, scarred, and has no functional myocardium (ie, akinetic, dyskinetic).</p><p>The pathologic findings of LV aneurysm are discussed elsewhere in this topic. (See <a class="local">'Pathophysiology'</a> above.)</p><p>The differential diagnosis includes LV pseudoaneurysm and LV diverticulum. In contrast with an LV pseudoaneurysm, a true LV aneurysm arises from a broad base or "neck" and the myocardium, though fibrotic and scarred, is not interrupted. The characteristics of LV pseudoaneurysms are discussed elsewhere in this topic (see <a class="local">'Diagnosis'</a> below). An LV diverticulum is a rare finding that occurs either as a congenital anomaly or in patients with hypertrophic cardiomyopathy [<a href="#rid20">20,21</a>].</p><p class="headingAnchor" id="H13"><span class="h2">Management</span></p><p class="headingAnchor" id="H2795399330"><span class="h3">Therapy for reduced systolic function</span><span class="headingEndMark"> — </span>All patients with an LV aneurysm and LV systolic dysfunction should receive therapy appropriate for ischemic cardiomyopathy (eg, revascularization, medical therapy, cardiac resynchronization therapy) [<a href="#rid22">22</a>]. The general approach to the management of LV systolic dysfunction is described elsewhere. (See  <a class="medical medical_review" href="/z/d/html/121085.html" rel="external">"Overview of the management of heart failure with reduced ejection fraction in adults"</a> and  <a class="medical medical_review" href="/z/d/html/1507.html" rel="external">"Treatment of ischemic cardiomyopathy"</a>.)</p><p class="headingAnchor" id="H3036220338"><span class="h3">Anticoagulation</span><span class="headingEndMark"> — </span>We evaluate for the presence of thrombus in all patients with evidence of an LV aneurysm. Our approach to anticoagulation is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/90.html" rel="external">"Left ventricular thrombus after acute myocardial infarction", section on 'Prevention of embolic events'</a>.)</p><p class="headingAnchor" id="H756560133"><span class="h3">Role of aneurysmectomy</span><span class="headingEndMark"> — </span>The scenarios in which aneurysmectomy may be considered include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with an LV aneurysm who require cardiac surgery </strong>– In patients with an LV aneurysm who will undergo cardiac surgery (eg, coronary artery bypass graft surgery [CABG]), LV aneurysmectomy may be included as part of the planned surgery. The decision to perform aneurysmectomy at the time of cardiac surgery is typically determined by the surgeon who must decide whether aneurysmectomy is required to successfully perform the planned surgery (eg, mitral valve surgery) or is likely to be of benefit regardless of the planned surgery.</p><p></p><p class="bulletIndent1">North American guidelines give a weak recommendation for performance of aneurysmectomy at the time of CABG in patients with the features noted above, while European guidelines do not mention aneurysmectomy [<a href="#rid23">23,24</a>].</p><p></p><p class="bulletIndent1">There are no reliable data to guide patient selection or the exact approach to surgery (eg, Dor myoplasty, linear repair) [<a href="#rid25">25</a>]. Some patients enrolled in the STICH trial likely had an LV aneurysm and aneurysmectomy, but the anatomy and surgery performed in STICH were not well described, which limits the direct application of this trial's results to patients with an LV aneurysm [<a href="#rid26">26</a>]. Further details on this study are described elsewhere in this topic. (See <a class="local">'Surgery for left ventricular enlargement'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with an LV aneurysm without another indication for cardiac surgery</strong> –<strong> </strong>In patients with HF who receive maximal medical therapy and have no indication for cardiac surgery but who have a large aneurysm, large LV thrombus, or arrhythmias due to an aneurysm, isolated LV aneurysmectomy is an option for therapy if no other options (eg, radiofrequency ablation, heart transplantation) are feasible or appropriate.</p><p></p><p class="bulletIndent1">Isolated aneurysmectomy is not mentioned in professional guidelines, and its efficacy is unclear.</p><p></p><p class="headingAnchor" id="H3542536684"><span class="h3">Approach to severe heart failure</span><span class="headingEndMark"> — </span>In patients with an LV aneurysm who have severe HF symptoms (eg, New York Heart Association class IV HF symptoms) refractory to optimal medical and device-based treatments, we continue optimal therapy and evaluate the patient for the appropriateness of advanced HF therapies such as heart transplantation and durable mechanical circulatory support. In rare scenarios, aneurysmectomy may be an option for therapy. (See <a class="local">'Role of aneurysmectomy'</a> above.)</p><p class="headingAnchor" id="H3512239518"><span class="h3">Approach to ventricular arrhythmias</span><span class="headingEndMark"> — </span>In patients with an LV aneurysm who have refractory ventricular arrhythmias despite optimal medical management, VT ablation is an option that may reduce the frequency of ventricular arrhythmias. In most patients with an LV aneurysm who are under consideration for VT ablation, an assessment for advanced HF therapies is warranted. (See  <a class="medical medical_review" href="/z/d/html/1058.html" rel="external">"Electrical storm and incessant ventricular tachycardia", section on 'Subsequent management'</a>.)</p><p class="headingAnchor" id="H1357083254"><span class="h3">Longitudinal monitoring</span><span class="headingEndMark"> — </span>In patients diagnosed with LV aneurysm, we typically monitor for changes in LV function, changes in aneurysm dimensions, and related complications with echocardiography. Following acute MI and aneurysm formation, we may obtain imaging every 6 to 12 months to monitor for adverse remodeling and thrombus formation. After approximately one year, the frequency of echocardiographic monitoring is individualized to the patient.</p><p class="headingAnchor" id="H1902484606"><span class="h2">Prognosis and risk of rupture</span><span class="headingEndMark"> — </span>The natural history of patients with LV aneurysm who survive the initial MI is not well described. However, the presence of an LV aneurysm likely confers a worse prognosis than for similar patients who do not have an LV aneurysm. Based on our experience, morbidity and mortality in patients with an LV aneurysm is related to its size, whether the aneurysmal segment is dyskinetic or akinetic, the extent of coronary disease (single versus multivessel), and the overall function of the LV.</p><p>The risk factors for LV aneurysm rupture are unclear. The risk of aneurysm rupture may increase with the size of the aneurysm and decrease as the aneurysm becomes older and more fibrotic. In our experience, rupture is rare. There are no data that allow for accurate estimation of the risk of this fatal complication.</p><p class="headingAnchor" id="H19"><span class="h1">LEFT VENTRICULAR PSEUDOANEURYSM</span></p><p class="headingAnchor" id="H20"><span class="h2">Epidemiology and clinical presentation</span><span class="headingEndMark"> — </span>LV pseudoaneurysm is a rare complication of MI, cardiac surgery, and trauma [<a href="#rid27">27</a>]. Risk factors for LV pseudoaneurysm are similar to those of ventricular free wall rupture (see  <a class="medical medical_review" href="/z/d/html/63.html" rel="external">"Acute myocardial infarction: Mechanical complications", section on 'Risk factors'</a>). Right ventricular pseudoaneurysms are typically associated with prior cardiac surgery in patients with congenital heart disease [<a href="#rid28">28</a>].</p><p>The most frequent symptoms associated with LV pseudoaneurysm are chest pain and dyspnea [<a href="#rid27">27,28</a>]. Rarely, a pseudoaneurysm may present as persistent pericarditis. Sudden cardiac death was the presenting manifestation in approximately 3 percent. Between 12 and 25 percent of patients who have a ventricular pseudoaneurysm may be asymptomatic. Additional features of the presentation include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Murmur</strong> – Murmurs are present in about two-thirds of patients [<a href="#rid27">27</a>]. The murmur is often present in both systole and diastole, but if isolated to systole, it may be indistinguishable from the murmur of mitral regurgitation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG changes</strong> – ECG changes occur in more than 95 percent of patients and include ST-segment elevation in 20 percent and nonspecific changes in the remainder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiography</strong> – In patients with a pseudoaneurysm, chest radiography may show cardiomegaly with or without calcification.</p><p></p><p class="headingAnchor" id="H1669827966"><span class="h2">Evaluation</span><span class="headingEndMark"> — </span>Similar to LV aneurysm, LV pseudoaneurysm should be suspected in patients who present with signs or symptoms of acute MI or HF. In patients with prior cardiac surgery or trauma, a high index of suspicion is required to pursue specific testing for an LV pseudoaneurysm.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute presentation with STEMI</strong> – In patients who present with acute MI (typically ST-elevation MI [STEMI]), the evaluation for acute MI typically includes a detailed history, physical examination, ECG, and chest radiography. If these or other studies (eg, point-of-care ultrasonography [POCUS]) suggest the presence of an LV pseudoaneurysm (eg, mass on chest radiography, circumferential pericardial effusion) in a patient who will undergo percutaneous coronary intervention (PCI), contrast ventriculography should be performed during the PCI procedure. In similar patients in whom contrast ventriculography cannot be performed, transthoracic or transesophageal echocardiography should be performed as soon as possible.</p><p></p><p class="bulletIndent1">If the diagnosis is unclear after contrast ventriculography or echocardiography, CMR imaging or CCTA should be performed when clinically feasible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation without STEMI</strong> – In patients who present nonurgently, echocardiography, CMR imaging, or CCTA are all reasonable options for initial imaging.</p><p></p><p>Findings on imaging studies commonly obtained to assess for LV aneurysm include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Echocardiography</strong> – On echocardiography, LV pseudoaneurysms have a narrow neck that is typically less than 40 percent of the maximal aneurysm diameter and causes an abrupt interruption in the ventricular myocardium. In contrast, true aneurysms are nearly as wide at the neck as they are at the apex  (<a class="graphic graphic_movie graphicRef62247" href="/z/d/graphic/62247.html" rel="external">movie 1</a> and <a class="graphic graphic_movie graphicRef72045" href="/z/d/graphic/72045.html" rel="external">movie 2</a> and <a class="graphic graphic_diagnosticimage graphicRef71546" href="/z/d/graphic/71546.html" rel="external">image 17</a>) and there is no interruption of the ventricular myocardium (though it may be fibrotic or scarred).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Computed tomography or magnetic resonance imaging</strong> – The findings on CCTA and CMR imaging are similar to those on echocardiography, but CCTA and CMR can often identify the location of the aneurysm with greater detail  (<a class="graphic graphic_diagnosticimage graphicRef106331" href="/z/d/graphic/106331.html" rel="external">image 18</a>) [<a href="#rid29">29,30</a>]. In addition, CCTA and CMR allow for more accurate measurement of the characteristics of the pseudoaneurysm (eg, ratio between the maximal internal width of the orifice to the maximal parallel internal diameter) and may provide other information relevant to management (eg, coronary anatomy with CCTA, characterization of the pseudoaneurysm tissue with CMR).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contrast ventriculography</strong> – Contrast ventriculography demonstrates a narrow orifice leading to a saccular collection of blood that is contiguous with the LV cavity and that does not contain evidence of coronary artery circulation  (<a class="graphic graphic_diagnosticimage graphicRef93484" href="/z/d/graphic/93484.html" rel="external">image 19</a>) [<a href="#rid31">31</a>]. Ventriculography leads to a definitive diagnosis in over 85 percent of patients [<a href="#rid27">27</a>].</p><p></p><p class="headingAnchor" id="H1747371688"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>An LV pseudoaneurysm, also referred to as a false aneurysm or contained rupture, forms when the myocardium ruptures and the rupture is contained by adherent pericardium or scar tissue [<a href="#rid32">32</a>]. LV pseudoaneurysm is clinically diagnosed by identifying an outpouching of the LV that arises from a breach in the myocardial wall and is contained only by pericardium (ie, not myocardium).</p><p>The differential diagnosis includes true LV aneurysm and LV diverticulum. Unlike a true LV aneurysm, an LV pseudoaneurysm contains no endocardium or myocardium.</p><p class="headingAnchor" id="H23"><span class="h2">Treatment and prognosis</span><span class="headingEndMark"> — </span>The treatment of patients with an LV pseudoaneurysm typically involves acute hemodynamic stabilization and urgent surgical repair:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute management</strong> – Patients who present with acute MI and pseudoaneurysm should be treated with all therapies appropriate for STEMI. (See  <a class="medical medical_review" href="/z/d/html/66.html" rel="external">"Overview of the acute management of ST-elevation myocardial infarction"</a>.)</p><p></p><p class="bulletIndent1">For patients who present with cardiogenic shock, therapy may also include inotropic support and temporary mechanical circulatory support as appropriate. The approach to treatment of cardiogenic shock in acute MI is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/83.html" rel="external">"Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical repair</strong> – In patients with LV pseudoaneurysm, medical therapy alone is associated with a high risk of mortality that may exceed 50 percent [<a href="#rid27">27</a>]. Thus, in patients who can safely undergo surgery, surgical repair is required. The goal of surgery is to prevent rupture and improve myocardial function. In patients who cannot undergo surgical repair, other options for treatment may include durable mechanical circulatory support device placement and urgent heart transplantation. Catheter-based occlusion has been reported, but the efficacy of this procedure is unclear [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1">Surgery is typically performed urgently. Surgery consists of resection of the pseudoaneurysm and repair of the LV wall defect with reapproximation of the myocardium with or without use of a patch [<a href="#rid34">34</a>]. The mortality after pseudoaneurysm repair is described in older studies in which the perioperative mortality was less than 10 percent and greater in patients who required additional surgery (eg, mitral valve replacement) [<a href="#rid35">35,36</a>].</p><p></p><p class="headingAnchor" id="H3644516866"><span class="h1">SURGERY FOR LEFT VENTRICULAR ENLARGEMENT</span><span class="headingEndMark"> — </span>In patients who have ventricular enlargement without an aneurysm, we suggest not performing LV restoration surgery. The benefit of this surgery is unclear and other surgical options for end-stage HF (eg, LV assist device placement, transplantation) may be available.</p><p>The rationale for surgical LV restoration is to reduce LV volume to improve mechanical function of the LV. Surgical LV restoration was evaluated in the STICH trial, which included 1000 patients with ischemic cardiomyopathy and an anterior akinetic or dyskinetic region of myocardium amenable to ventricular reconstruction [<a href="#rid26">26</a>]. Among patients randomly assigned to either LV reconstruction with coronary artery bypass graft surgery (CABG) or CABG alone, the risk of death or HF hospitalization was similar (58 versus 59 percent; hazard ratio 0.99, 95% CI 0.84-1.17).</p><p class="headingAnchor" id="H3715366354"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114034.html" rel="external">"Society guideline links: Non-ST-elevation acute coronary syndromes (non-ST-elevation myocardial infarction)"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/113180.html" rel="external">"Society guideline links: ST-elevation myocardial infarction (STEMI)"</a>.)</p><p class="headingAnchor" id="H460775224"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Left ventricular aneurysm</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Epidemiology</strong> – Left ventricular (LV) aneurysms are rare and typically occur as a complication of acute myocardial infarction (MI). Other causes of LV aneurysm include prior cardiac surgery, Chagas disease, and hypertrophic cardiomyopathy.</p><p></p><p class="bulletIndent2">The risk factors for LV aneurysm after MI include anterior wall infarction, delayed or incomplete reperfusion, and the absence of extensive collateralization. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical manifestations –</strong>In patients with acute MI, the presence of an LV aneurysm is typically identified with imaging performed for diagnosis and management of acute MI. Other syndromes that may indicate the presence of an LV aneurysm include angina, heart failure (HF), ventricular arrhythmias, systemic embolization, and sudden death.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluation for LV aneurysm</strong> –<strong> </strong>In patients suspected of having an LV aneurysm, echocardiography is typically the first step in evaluation  (<a class="graphic graphic_movie graphicRef62247" href="/z/d/graphic/62247.html" rel="external">movie 1</a> and <a class="graphic graphic_movie graphicRef72045" href="/z/d/graphic/72045.html" rel="external">movie 2</a>) [<a href="#rid18">18,19</a>]. In most patients, echocardiography is sufficient to establish the diagnosis. In patients with nondiagnostic echocardiographic images or who require further characterization of the ventricular wall (eg, to differentiate between aneurysm and pseudoaneurysm), additional imaging with cardiac computed tomographic angiography (CCTA), cardiovascular magnetic resonance (CMR) imaging  (<a class="graphic graphic_diagnosticimage graphicRef93512" href="/z/d/graphic/93512.html" rel="external">image 12</a>), nuclear imaging  (<a class="graphic graphic_diagnosticimage graphicRef93508" href="/z/d/graphic/93508.html" rel="external">image 15</a>), or contrast ventriculography  (<a class="graphic graphic_diagnosticimage graphicRef93509" href="/z/d/graphic/93509.html" rel="external">image 16</a>) may be required.</p><p></p><p class="bulletIndent2">In patients diagnosed with an LV aneurysm, a dedicated study for assessment of LV thrombus should be performed. The approach to diagnosis of LV thrombus is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/90.html" rel="external">"Left ventricular thrombus after acute myocardial infarction", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Management</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Therapy for reduced systolic function</strong> – All patients with an LV aneurysm and LV systolic dysfunction should receive therapy appropriate for ischemic cardiomyopathy (eg, revascularization, medical therapy, device therapy) [<a href="#rid22">22</a>]. The general approach to the management of LV systolic dysfunction is described elsewhere. (See  <a class="medical medical_review" href="/z/d/html/121085.html" rel="external">"Overview of the management of heart failure with reduced ejection fraction in adults"</a> and  <a class="medical medical_review" href="/z/d/html/1507.html" rel="external">"Treatment of ischemic cardiomyopathy"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Anticoagulation</strong> – We evaluate for the presence of thrombus in all patients with evidence of an LV aneurysm. Our approach to anticoagulation is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/90.html" rel="external">"Left ventricular thrombus after acute myocardial infarction", section on 'Prevention of embolic events'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Aneurysmectomy in addition to other cardiac surgery</strong> – In patients with an LV aneurysm who will undergo cardiac surgery (eg, coronary artery bypass graft surgery [CABG]), LV aneurysmectomy may be included as part of the planned surgery. The decision to perform aneurysmectomy at the time of cardiac surgery is typically determined by the surgeon who must decide whether aneurysmectomy is required to successfully perform the planned surgery (eg, mitral valve surgery) or is likely to be of benefit regardless of the planned surgery. (See <a class="local">'Role of aneurysmectomy'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Isolated aneurysmectomy</strong> – In patients with HF who receive maximal medical therapy but who have a large aneurysm, large LV thrombus, or arrhythmias due to an aneurysm, isolated LV aneurysmectomy is an option for therapy if no other options (eg, radiofrequency ablation, heart transplantation) are feasible or appropriate.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Approach to severe heart failure</strong> – In patients with an LV aneurysm who have severe HF symptoms (eg, New York Heart Association class IV HF symptoms) refractory to optimal medical and device-based treatments, we continue optimal therapy and evaluate the patient for the appropriateness of advanced HF therapies such as heart transplantation and durable mechanical circulatory support. (See <a class="local">'Approach to severe heart failure'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Approach to ventricular arrhythmias </strong>– In patients with an LV aneurysm who have refractory ventricular arrhythmias despite optimal medical management, ventricular tachycardia (VT) ablation is an option that may reduce the frequency of ventricular arrhythmias. (See  <a class="medical medical_review" href="/z/d/html/1058.html" rel="external">"Electrical storm and incessant ventricular tachycardia", section on 'Subsequent management'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Longitudinal monitoring</strong> – In patients diagnosed with LV aneurysm, we typically monitor for changes in LV function, changes in aneurysm dimensions, and related complications with routine echocardiography at least every three months. (See <a class="local">'Longitudinal monitoring'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Left ventricular pseudoaneurysm</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Epidemiology and clinical presentation – </strong>LV pseudoaneurysm is a rare complication of MI, cardiac surgery, and trauma. The first indication of an LV pseudoaneurysm may be sudden death, which results from rupture of the pseudoaneurysm. Right ventricular pseudoaneurysms are typically associated with prior cardiac surgery in patients with congenital heart disease. (See <a class="local">'Epidemiology and clinical presentation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluation – </strong>Similar to LV aneurysm, LV pseudoaneurysm should be suspected in patients who present with signs or symptoms of acute MI or HF. In patients with prior cardiac surgery or trauma, a high index of suspicion is required to pursue specific testing for an LV pseudoaneurysm.</p><p></p><p class="bulletIndent2">The initial approach to diagnosis is contrast ventriculography  (<a class="graphic graphic_diagnosticimage graphicRef93484" href="/z/d/graphic/93484.html" rel="external">image 19</a>) for patients with ST-elevation MI (STEMI) who will undergo percutaneous coronary intervention (PCI) and echocardiography  (<a class="graphic graphic_diagnosticimage graphicRef71546" href="/z/d/graphic/71546.html" rel="external">image 17</a>) for other patients. (See <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnosis – </strong>An LV pseudoaneurysm, also referred to as a false aneurysm or contained rupture, forms when the myocardium ruptures and the rupture is contained by adherent pericardium or scar tissue [<a href="#rid32">32</a>]. LV pseudoaneurysm is clinically diagnosed by identifying an outpouching of the LV that arises from a breach in the myocardial wall and is contained only by pericardium (ie, not myocardium). (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2">The differential diagnosis includes true LV aneurysm and LV diverticulum. Unlike a true LV aneurysm, an LV pseudoaneurysm contains no endocardium or myocardium.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment and prognosis</strong> — The treatment of patients with an LV pseudoaneurysm typically involves acute hemodynamic stabilization and definitive repair:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Acute management</strong> – Patients who present with acute MI and pseudoaneurysm should be treated with all therapies appropriate for STEMI. (See  <a class="medical medical_review" href="/z/d/html/66.html" rel="external">"Overview of the acute management of ST-elevation myocardial infarction"</a>.)</p><p></p><p class="bulletIndent3">For patients who present with cardiogenic shock, therapy may also include inotropic support and temporary mechanical circulatory support as appropriate. (See  <a class="medical medical_review" href="/z/d/html/83.html" rel="external">"Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Surgical repair</strong> – In patients with LV pseudoaneurysm, medical therapy alone is associated with a high risk of mortality that may exceed 50 percent. Thus, in patients who can safely undergo surgery, surgical repair is required. In patients who cannot undergo surgical repair, other options for treatment may include durable mechanical circulatory support device placement and urgent heart transplantation. (See <a class="local">'Treatment and prognosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgery for left ventricular enlargement</strong> – In patients who have ventricular enlargement without an aneurysm, we suggest not performing LV restoration surgery (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>).</p><p></p><p class="headingAnchor" id="H1017129291"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Oz M Shapira, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Dubnow MH, Burchell HB, Titus JL. Postinfarction ventricular aneurysm. A clinicomorphologic and electrocardiographic study of 80 cases. Am Heart J 1965; 70:753.</a></li><li><a class="nounderline abstract_t">Rao G, Zikria EA, Miller WH, et al. Experience with sixty consecutive ventricular aneurysm resections. Circulation 1974; 50:II149.</a></li><li><a class="nounderline abstract_t">Gorlin R, Klein MD, Sullivan JM. Prospective correlative study of ventricular aneurysm. Mechanistic concept and clinical recognition. Am J Med 1967; 42:512.</a></li><li><a class="nounderline abstract_t">Kitamura S, Kay JH, Krohn BG, et al. Geometric and functional abnormalities of the left ventricle with a chronic localized noncontractile area. Am J Cardiol 1973; 31:701.</a></li><li><a class="nounderline abstract_t">Nicolosi AC, Spotnitz HM. Quantitative analysis of regional systolic function with left ventricular aneurysm. Circulation 1988; 78:856.</a></li><li><a class="nounderline abstract_t">Klein MD, Herman MV, Gorlin R. A hemodynamic study of left ventricular aneurysm. Circulation 1967; 35:614.</a></li><li class="breakAll">Mirsky I. Elastic properties of the myocardium: A quantitative approach with physiological and clinical applications. In: Handbook of physiology, Vol 1: The heart, Berne LM (Ed), American Physiological Society, Bethesda 1979. p.501.</li><li class="breakAll">Glower DG, Lowe EL. Left ventricular aneurysm. In: Cardiac Surgery in the Adult, Edmunds LH (Ed), McGraw-Hill, New York 1997. p.677.</li><li><a class="nounderline abstract_t">Tikiz H, Balbay Y, Atak R, et al. The effect of thrombolytic therapy on left ventricular aneurysm formation in acute myocardial infarction: relationship to successful reperfusion and vessel patency. Clin Cardiol 2001; 24:656.</a></li><li><a class="nounderline abstract_t">Nagle RE, Williams DO. Proceedings: Natural history of ventricular aneurysm without surgical treatment. Br Heart J 1974; 36:1037.</a></li><li><a class="nounderline abstract_t">SCHLICHTER J, HELLERSTEIN HK, KATZ LN. Aneurysm of the heart: a correlative study of one hundred and two proved cases. Medicine (Baltimore) 1954; 33:43.</a></li><li><a class="nounderline abstract_t">Harken AH. Surgical treatment of cardiac arrhythmias. Sci Am 1993; 269:68.</a></li><li><a class="nounderline abstract_t">Waldo AL, Arciniegas JG, Klein H. Surgical treatment of life-threatening ventricular arrhythmias: the role of intraoperative mapping and consideration of the presently available surgical techniques. Prog Cardiovasc Dis 1981; 23:247.</a></li><li><a class="nounderline abstract_t">Cabin HS, Roberts WC. Left ventricular aneurysm, intraaneurysmal thrombus and systemic embolus in coronary heart disease. Chest 1980; 77:586.</a></li><li><a class="nounderline abstract_t">Sherman DG, Dyken ML, Fisher M, et al. Antithrombotic therapy for cerebrovascular disorders. Chest 1989; 95:140S.</a></li><li><a class="nounderline abstract_t">Reeder GS, Lengyel M, Tajik AJ, et al. Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization. Mayo Clin Proc 1981; 56:77.</a></li><li><a class="nounderline abstract_t">Vlodaver Z, Coe JI, Edwards JE. True and false left ventricular aneurysms. Propensity for the altter to rupture. Circulation 1975; 51:567.</a></li><li><a class="nounderline abstract_t">Arvan S, Varat MA. Persistent ST-segment elevation and left ventricular wall abnormalities: a 2-dimensional echocardiographic study. Am J Cardiol 1984; 53:1542.</a></li><li><a class="nounderline abstract_t">Matsumoto M, Watanabe F, Goto A, et al. Left ventricular aneurysm and the prediction of left ventricular enlargement studied by two-dimensional echocardiography: quantitative assessment of aneurysm size in relation to clinical course. Circulation 1985; 72:280.</a></li><li><a class="nounderline abstract_t">Hamada M, Teruyama Y, Yamashita H, et al. Congenital left ventricular diverticulum: diagnostic usefulness of color Doppler echocardiography and computed tomography. Circulation 2013; 128:e451.</a></li><li><a class="nounderline abstract_t">Germans T, Dijkmans PA, Wilde AA, et al. Images in cardiovascular medicine. Prominent crypt formation in the inferoseptum of a hypertrophic cardiomyopathy mutation carrier mimics noncompaction cardiomyopathy. Circulation 2007; 115:e610.</a></li><li><a class="nounderline abstract_t">Mourdjinis A, Olsen E, Raphael MJ, Mounsey JP. Clinical diagnosis and prognosis of ventricular aneurysm. Br Heart J 1968; 30:497.</a></li><li><a class="nounderline abstract_t">Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145:e895.</a></li><li><a class="nounderline abstract_t">McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42:3599.</a></li><li><a class="nounderline abstract_t">Zheng Z, Fan H, Feng W, et al. Surgery of left ventricular aneurysm: a propensity score-matched study of outcomes following different repair techniques. Interact Cardiovasc Thorac Surg 2009; 9:431.</a></li><li><a class="nounderline abstract_t">Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009; 360:1705.</a></li><li><a class="nounderline abstract_t">Frances C, Romero A, Grady D. Left ventricular pseudoaneurysm. J Am Coll Cardiol 1998; 32:557.</a></li><li><a class="nounderline abstract_t">Yeo TC, Malouf JF, Oh JK, Seward JB. Clinical profile and outcome in 52 patients with cardiac pseudoaneurysm. Ann Intern Med 1998; 128:299.</a></li><li><a class="nounderline abstract_t">Konen E, Merchant N, Gutierrez C, et al. True versus false left ventricular aneurysm: differentiation with MR imaging--initial experience. Radiology 2005; 236:65.</a></li><li><a class="nounderline abstract_t">Kerkhoff GO, Höfs C, Roer N, et al. Images in cardiovascular medicine. Left ventricular pseudoaneurysm: clinical role of cardiovascular magnetic resonance imaging. Circulation 2004; 109:e222.</a></li><li><a class="nounderline abstract_t">al-Saadon K, Walley VM, Green M, Beanlands DS. Angiographic diagnosis of true and false LV aneurysms after inferior wall myocardial infarction. Cathet Cardiovasc Diagn 1995; 35:266.</a></li><li><a class="nounderline abstract_t">Dachman AH, Spindola-Franco H, Solomon N. Left ventricular pseudoaneurysm. Its recognition and significance. JAMA 1981; 246:1951.</a></li><li><a class="nounderline abstract_t">Dudiy Y, Jelnin V, Einhorn BN, et al. Percutaneous closure of left ventricular pseudoaneurysm. Circ Cardiovasc Interv 2011; 4:322.</a></li><li><a class="nounderline abstract_t">Alshammari BS, Reardon MJ, Nabi F. Late Left Ventricular Pseudoaneurysm after Acute Myocardial Infarction. Methodist Debakey Cardiovasc J 2017; 13:169.</a></li><li><a class="nounderline abstract_t">Bolooki H. Surgical treatment of complications of acute myocardial infarction. JAMA 1990; 263:1237.</a></li><li><a class="nounderline abstract_t">Komeda M, David TE. Surgical treatment of postinfarction false aneurysm of the left ventricle. J Thorac Cardiovasc Surg 1993; 106:1189.</a></li></ol></div><div id="topicVersionRevision">Topic 60 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5842520" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Postinfarction ventricular aneurysm. A clinicomorphologic and electrocardiographic study of 80 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4843618" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Experience with sixty consecutive ventricular aneurysm resections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6024720" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prospective correlative study of ventricular aneurysm. Mechanistic concept and clinical recognition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4706727" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Geometric and functional abnormalities of the left ventricle with a chronic localized noncontractile area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3168193" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Quantitative analysis of regional systolic function with left ventricular aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6024006" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A hemodynamic study of left ventricular aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6024006" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A hemodynamic study of left ventricular aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6024006" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A hemodynamic study of left ventricular aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11594411" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The effect of thrombolytic therapy on left ventricular aneurysm formation in acute myocardial infarction: relationship to successful reperfusion and vessel patency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4279684" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Proceedings: Natural history of ventricular aneurysm without surgical treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13132257" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Aneurysm of the heart: a correlative study of one hundred and two proved cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8337598" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Surgical treatment of cardiac arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7008078" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Surgical treatment of life-threatening ventricular arrhythmias: the role of intraoperative mapping and consideration of the presently available surgical techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7363674" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Left ventricular aneurysm, intraaneurysmal thrombus and systemic embolus in coronary heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2644097" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Antithrombotic therapy for cerebrovascular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7464234" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1132088" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : True and false left ventricular aneurysms. Propensity for the altter to rupture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6731299" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Persistent ST-segment elevation and left ventricular wall abnormalities: a 2-dimensional echocardiographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3159507" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Left ventricular aneurysm and the prediction of left ventricular enlargement studied by two-dimensional echocardiography: quantitative assessment of aneurysm size in relation to clinical course.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24344066" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Congenital left ventricular diverticulum: diagnostic usefulness of color Doppler echocardiography and computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17548735" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Images in cardiovascular medicine. Prominent crypt formation in the inferoseptum of a hypertrophic cardiomyopathy mutation carrier mimics noncompaction cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5659397" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Clinical diagnosis and prognosis of ventricular aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35363499" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34447992" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19515672" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Surgery of left ventricular aneurysm: a propensity score-matched study of outcomes following different repair techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19329820" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Coronary bypass surgery with or without surgical ventricular reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9741493" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Left ventricular pseudoaneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9471934" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clinical profile and outcome in 52 patients with cardiac pseudoaneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15955851" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : True versus false left ventricular aneurysm: differentiation with MR imaging--initial experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15159331" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Images in cardiovascular medicine. Left ventricular pseudoaneurysm: clinical role of cardiovascular magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7553838" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Angiographic diagnosis of true and false LV aneurysms after inferior wall myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7288976" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Left ventricular pseudoaneurysm. Its recognition and significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21791672" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Percutaneous closure of left ventricular pseudoaneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29744003" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Late Left Ventricular Pseudoaneurysm after Acute Myocardial Infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2406477" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Surgical treatment of complications of acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8246558" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Surgical treatment of postinfarction false aneurysm of the left ventricle.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
